There is no agreement in the literature on selecting the principal parameters that contribute to explain the different outcomes in supratentorial astrocytomas. Hence, we designed a global study using morphologic parameters and DNA quantification measured by flow cytometry (FCM) and image analysis (IA) on 116 tumors contrasting the results with patients' survival in a univariate and multivariate study. In the Kaplan-Meier study besides the necrosis (p<0.0001) there were other parameters with significant prognostic value such as nuclear atypia (p=0.0001), presence of anaplastic large cells (p=0.0003) and the morphology of the tumor vessels (p=0.009). Proliferative parameters like mitotic index, cell density, the cell fraction in S phase or G2/M phase, and the proliferative phase measured by image analysis (IA) or ploidy patterns did not influence the prognosis. In the Cox's proportional hazards model the presence of necrosis remained as the only prognostic predictor (p=0.001) and increased 5.9 times the risk of mortality in gliomas.
1. Burger PC, Vogel FS, Green SV, et al. Glioblastoma multiforme and anaplastic astrocytoma. Pathological criteria and prognostic implications. Cancer56: 1106-1111, 1985
2.
2. Daumas-Duport C, Scheithauer B, O'Fallon J, et al. Grading of astrocytomas. A simple and reproducible method. Cancer62:2152-2165, 1988
3.
3. Bailey P, Cushing H (eds). A classification of the tumors of the glioma group on a histogenetic basis with a correlation study of prognosis. Lippincott, Philadelphia, 1926
4.
4. Kernohan J, Mabon R, Svien H, et al. A simplified classification of the gliomas. Staff Meet Mayo Clin24:71-75, 1949
5.
5. Ng H, Leung S.The new WHO classification of CNS tumors: A selective review. Adv Anat Pathol2:195-207, 1995
6.
6. Burger PC, Green SB. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer59:1617-1625, 1987
7.
7. Schiffer D, Chio A, Giordana MT, et al. Prognostic value of histologic factors in adult cerebral astrocytoma. Cancer61:1386-1393, 1988
8.
8. Selby DM, Woodard CA, Henry ML, Bernstein JJ. Are endothelial cell patterns indicative of grade?In vivo11:371-375, 1997
9.
9. Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H.Role of gemistocytes in astrocytoma progression. Lab Invest76:277-284, 1997
10.
10. Nazzaro JM, Neuwelt EA. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg73:331-344, 1990
11.
11. Nicolato A, Gerosa MA, Fina P, et al. Prognostic factors in low-grade supratentorial astrocytomas: A unimultivariate statistical analysis in 76 surgically treated adult patients. Surg Neurol44:208-221, 1995
12.
12. Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G, et al. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery41:1028-1036, 1997
13.
13. Vavruch L, Nordenskjold B, Carstensen J, Enestrom S.Prognostic value of flow cytometry and correlation to some conventional prognostic factors: A retrospective study of archival specimens of 134 astrocytomas. J Neurosurg85:146-151, 1996
14.
14. Danova M, Giaretti W, Merlo F, et al. Prognostic significance of nuclear DNA content in human neuroepithelial tumors. Int J Cancer48:663-667, 1991
15.
15. Appley AJ, Fitzgibbons PL, Chandrasoma PT, et al. Multiparameter flow cytometric analysis of neoplasms of the CNS: Correlation of nuclear antigen p 105 and DNA content with clinical behavior. Neurosurgery27:83-96, 1990
16.
16. Sorensen FB, Braendgaard H, Chistiansen AO, et al. Stereological estimates of nuclear volume and other quantitative variables in supratentorial brain tumors. Practical technique and use in prognostic evaluation. J Neurooncol10:253-262, 1991
17.
17. Salmon I, Kiss R.Relationship between proliferative activity and ploidy level in a series of 530 human brain tumors, including astrocytoma, meningiomas, schwannomas, and metastases. Hum Pathol24:329-335, 1993
18.
18. Yoshii Y, Saito A, Nose T. Nuclear morphometry and DNA densitometry of human aliomas by image analysis. J Neurooncol26:1-9, 1995
19.
19. Hedley DW, Friedlander ML, Taylor IW, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem3l:1333-1335, 1983
20.
20. Perez-Hoyo S.Analisis de Supervivencia. Quaderns de salut putblica i administracio de serveis de salut. 11:1-37, 1997
21.
21. Qing-cheng X, Pei-yu P, Yu-shan Y, et al. A survey of 790 cases of astrocytomas. Clin Neurol Neurosurg92:27-33, 1990
22.
22. Wurschmidt F, Bunemann H, Heilmann HP. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy. Strahlenther Onkol171:315-321, 1995
23.
23. Germano I, Ito M, Cho KG, et al. Correlation of histopathological features and proliferative potential of gliomas. J Neurosurg70:701-706, 1989
24.
24. Fulling KH, Garcia DM. Anaplastic astrocytoma of the adult cerebrum. Prognostic values of histologic features. Cancer55:928-931, 1985
25.
25. Paulus W, Peiffer J.Intratumoral histologic heterogeneity of gliomas. A quantitative study. Cancer64: 442-447, 1989
26.
26. Di X, Nishizaki T, Harada K, Kajiwara K, Nakayama H, Ito H.Proliferative potential of glioma cells and vascular components determined with monoclonal antibody MIB-1. J Exp Clin Cancer Res16:153-157, 1997
27.
27. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer77:362-372, 1996
28.
28. Cohen C.Image cytometric analysis in pathology. Hum Pathol27:482-493, 1996
29.
29. Yasue M, Tomita T, Engelhard H, et al. Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg70:385-391, 1989
30.
30. Coons SW, Davis JR, Way DL. Correlation of DNA content and histology in prognosis of astrocytomas. Am J Clin Pathol90:289-293, 1988
31.
31. Salmon I, Dewitte O, Pasteels J, et al. Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type. J Neurosurg80:877-883, 1994
32.
32. Sallinen P, Haapasalo H, Visakorpi T, et al. Prognostication of astrocytoma survival by ki-67 (mib-1), PCNA, and S-phase fraction using archival paraffinembedded samples. J Pathol174:275-282, 1994
33.
33. Cunningham JM, Kimmel DW, Scheithauer BW, O'Fallon JR, Novotny PJ, Jenkins RB. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationship and prognostic value. J Neurosurg86:121-130, 1997
34.
34. Ellison DW, Steart PV, Bateman AC, Pickering RM, Palmer JD, Weller RO. Prognostic indicators in a range of astrocytic tumors: An immunohistochemical study with ki-67 and p53 antibodies. J Neurol Neurosurg Psychiatry59:413-419, 1995
35.
35. Kirkegaard LJ, DeRose PB, Yao B, Cohen C.Image cytometric measurement of nuclear proliferation markers (mib1, PCNA) in astrocytomas prognostic significance. Am J Clin Pathol109:69-74, 1998
36.
36. Kiss R, Dewitte O, Decaestecker C, Camby I, et al. The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors. Am J Clin Pathol107:321-331, 1997
37.
37. Barker FG, Davis RL, Chang SM, Prados MD. Necrosis as a prognostic factor in glioblastoma multiforme. Cancer77:1161-1166, 1996
38.
38. Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat L.Bcl-2 distribution in neuroepithelial tumors: An immunohistochemical study. J Neurooncol27:101-109, 1996
39.
39. Tachibana O, Lampe J, Kleihues P, Ohgaki H.Preferential expression of Fas/APOl (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme. Acta Neuropathol92:431-434, 1996
40.
40. Drach LM, Kammermeier M, Neirich U, Jacobi G, et al. Accumulation of nuclear p53 protein and prognosis of astrocytomas in childhood and adolescence. Clin Neuropathol15:67-73, 1996
41.
41. Campomesi P, Ottagio L, Moro F, Urbini S, et al. Study on aneuploidy and p53 mutations in astrocytomas. Cancer Genet Cytogenet88:95-102, 1996
